Curr cancer drug targets impact factor

WebBentham Science Publishers. Bentham Science is a science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Our peer-reviewed scholarly journals and books have an ever-increasing readership of millions of researchers worldwide. WebIt is a companion to the highly regarded review journal Current Opinion in Pharmacology (2024 Journal Impact Factor 5.547, CiteScore 9.3) and is part of the Current Opinion and Research (CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a ...

Current Cancer Drug Targets Bentham Science

WebThe latest impact factor of CURRENT CANCER DRUG TARGETS and all the other SCI journals was released on 30th June 2024 by Clarivate. Through this web page, … WebCurrent Cancer Drug Targets is an impact factor journal that covers the full spectrum of cancer drug discovery and development for researchers and oncologists. newsletter banner Search anything here how many more minutes until 2:30 pm https://myyardcard.com

Current Cancer Drug Targets Bentham Science

WebScope Current Cancer Drug Targets aims to cover all the latest and outstanding developments in full spectrum of cancer drug discovery and development, including but … WebMay 27, 2024 · The impact score (IS) 2024 of Current Drug Safety is 1.22, which is computed in 2024 as per its definition.Current Drug Safety IS is decreased by a factor of 0.14 and approximate percentage change is -10.29% when compared to preceding year 2024, which shows a falling trend. The impact score (IS), also denoted as Journal … how big are geckos

Current Cancer Drug Targets - Impact Factor & Score 2024

Category:Current Cancer Drug Targets - Impact Factor & Score 2024

Tags:Curr cancer drug targets impact factor

Curr cancer drug targets impact factor

Current Research in Pharmacology and Drug Discovery Journal ...

WebA systematic review and meta-analysis on overall survival, failure-free survival and safety outcomes in patients with metastatic hormone-sensitive prostate cancer treated with new anti-androgens. Ramos-Esquivel, Allan; Garita-Rojas, Esteban; Masis-Marroquín, Adriana. Anti-Cancer Drugs. 34 (3):405-412, March 2024. Abstract. WebJul 13, 2024 · Current Neuropharmacology remains the most impactful title from our catalog, over the last year, and Its Impact Factor has increased to 7.708. Another highlight is Current Radiopharmaceuticals ...

Curr cancer drug targets impact factor

Did you know?

WebCurrent Cancer Drug Targets is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Ruiwen Zhang ( UH Drug Discovery Institute). … WebCurrent Cancer Drug Targets publishes original research papers in the field of Biological Sciences, Oncology and Cancer Research and Pharmacology. The journal is directed at …

WebCurrent Cancer Drug Targets is an impact factor journal that covers the full spectrum of cancer drug discovery and development for researchers and oncologists. ... Current … WebCurrent Cancer Drug Targets publishes original research papers in the field of Biological Sciences, Oncology and Cancer Research and Pharmacology. The journal is directed at professors, practitioners and researchers who keen on such topics of academic research. The primary research topics published in this academic venue include Cancer research ...

WebAims and scope. Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes. Current Cancer Drug Targets publishes ... WebHeat shock factor 1 (HSF1) was discovered in 1984 as the master regulator of the heat shock response. ... Curr Cancer Drug Targets. 2024;19(7):515-524. doi: …

WebThe latest impact score (IS) of the Current Cancer Drug Targets is 2.76.It is computed in ...

WebCurrent Cancer Drug Targets is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 96. It has an SJR impact factor of 0.732 and it has a best quartile of Q2. It is published in English. It has an SJR … how big are ghasts in minecraftWebCurrent Problems in Cancer. Journal Abbreviation: CURR PROB CANCER. Journal ISSN: 0147-0272. Year. Impact Factor (IF) Total Articles. Total Cites. 2024 (2024 update) 2.367. how many more minutes until it\u0027s morninghttp://www.eurekaselect.com/ how many more minutes until 6:15WebThe latest impact factor of Current Drug Therapy and all the other SCI journals was released on 30th June 2024 by Clarivate. Through this web page, researchers can check … how big are ghost shrimpWebCurr Cancer Drug Targets. 2015;15(8):739-49. doi: 10.2174/156800961508151001105814. ... These results suggest that the expression of CDK8 and its interactive genes has a profound impact on the response to adjuvant therapy in breast cancer in accordance with the role of CDK8 in chemotherapy-induced tumor … how many more minutes until 6:30WebImpact Factor: 4.850 5-Year Impact Factor: 3.111 Subscribe ISSN: 2212-392X (Online) ISSN: 1574-8936 (Print) Download PDF Flyer. Abstracted & Indexed in: ... Current Cancer Drug Targets. Impact Factor: 2.907 5-Year Impact Factor: 3.516 Subscribe ISSN: 1873-5576 (Online) ISSN: 1568-0096 (Print) how many more minutes until 7pm todayWebCurrent Cancer Drug Targets is an impact factor journal that covers the full spectrum of cancer drug discovery and development for researchers and oncologists. ... Current Cancer Drug Targets. ISSN (Print): 1568-0096 ISSN (Online): 1873-5576 Volume 23 , Issues 11, 2024. This journal supports open access ... how big are germs